Bio-Techne Declares Dividend
Rhea-AI Summary
Bio-Techne (NASDAQ: TECH) has announced a quarterly dividend of $0.08 per share for the quarter ended December 31, 2024. The dividend will be paid on February 28, 2025, to shareholders of record as of February 17, 2025.
The company, a global life sciences organization providing innovative tools and bioactive reagents for research and clinical diagnostics, reported net sales of approximately $1.2 billion in fiscal 2024. Bio-Techne employs around 3,100 people worldwide and maintains a portfolio of thousands of products supporting scientific investigations, biological processes research, drug discovery, and clinical testing.
Positive
- Generated $1.2 billion in net sales for fiscal 2024
- Maintains consistent quarterly dividend payment
- Extensive product portfolio serving research and clinical diagnostic markets
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, TECH gained 3.72%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately
Forward Looking Statements:
Our press releases may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act. Such statements involve risks and uncertainties that may affect the actual results of operations. Forward looking statements in this press release include statements regarding potential future repurchase of Bio-Techne common stock. The following important factors, among others, have affected and, in the future, could affect the Company's actual results and future share price: the effect of new branding and marketing initiatives, the integration of new businesses and leadership, the introduction and acceptance of new products, the funding and focus of the types of research by the Company's customers, the impact of the growing number of producers of biotechnology research products and related price competition, general economic conditions, customer site closures or supply chain issues, the impact of currency exchange rate fluctuations, and the costs and results of research and product development efforts of the Company and of companies in which the Company has invested or with which it has formed strategic relationships.
For additional information concerning such factors, see the section titled "Risk Factors" in the Company's annual report on Form 10-K and quarterly reports on Form 10-Q as filed with the Securities and Exchange Commission. We undertake no obligation to update or revise any forward-looking statements we make in our press releases due to new information or future events. Investors are cautioned not to place undue emphasis on these statements.
Contact: | David Clair, Vice President, Investor Relations & Corporate Development |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-declares-dividend-302368598.html
SOURCE Bio-Techne Corporation
FAQ
What is Bio-Techne's (TECH) quarterly dividend amount for Q4 2024?
When will Bio-Techne (TECH) pay its latest declared dividend?
What were Bio-Techne's (TECH) net sales in fiscal 2024?
How many employees does Bio-Techne (TECH) have globally?
What is the record date for Bio-Techne's (TECH) latest dividend?
